Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3

被引:55
作者
Asaka, J [1 ]
Terada, T [1 ]
Okuda, M [1 ]
Katsura, T [1 ]
Inui, K [1 ]
机构
[1] Kyoto Univ, Fac Med, Kyoto Univ Hosp, Dept Pharm,Sakyo Ku, Kyoto 6068507, Japan
关键词
gender difference; kidney; promoter; rOCT2; testosterone;
D O I
10.1007/s11095-006-9665-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Organic cation transporters 1-3 (OCT1-3 Slc22a1-3) mediate the membrane transport of organic cations in the kidney. We previously reported that rat (r)OCT2 expression in the kidney was regulated by testosterone. In this study, we examined the transcriptional mechanisms underlying the testosterone-dependent regulation of rOCT2 expression. Methods. Approximately 3000-bp fragments of the rOCT1-3 promoter region were isolated, and promoter activities were measured in the renal epithelial cell line LLC-PK1 with the coexpression of rat androgen receptor. Results. Among reporter constructs tested, only rOCT2 promoter activity was stimulated by testosterone. This stimulation was suppressed by nilutamide, an antiandrogen drug. Reporter assays using deletion construct, and mutational constructs of putative androgen response elements (ARE) in the rOCT2 promoter region suggested that two AREs, located at approximately -3000 and -1300, respectively, play an important role in the induction by testosterone. Conclusions. Testosterone induces the expression of rOCT2, but not of rOCT1 and rOCT3, via the AR-mediated transcriptional pathway. This is the first study to address the transcriptional mechanisms of testosterone-dependent gene regulation of the Slc22 family.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 42 条
[1]   New androgen response elements in the murine Pem promoter mediate selective transactivation [J].
Barbulescu, K ;
Geserick, C ;
Schüttke, I ;
Schleuning, WD ;
Haendler, B .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (10) :1803-1816
[2]   Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders [J].
Battmann, T ;
Branche, C ;
Bouchoux, F ;
Cerede, E ;
Philibert, D ;
Goubet, F ;
Teutsch, G ;
Gaillard-Kelly, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 64 (1-2) :103-111
[3]  
BOWMAN HM, 1972, P SOC EXP BIOL MED, V141, P258
[4]   Endocrine regulation of rat organic anion transporters [J].
Buist, SCN ;
Cherrington, NJ ;
Klaassen, CD .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) :559-564
[5]   Gender-specific and developmental influences on the expression of rat organic anion transporters [J].
Buist, SCN ;
Cherrington, NJ ;
Choudhuri, S ;
Hartley, DP ;
Klaassen, CD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :145-151
[6]   Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine [J].
Busch, AE ;
Karbach, U ;
Miska, D ;
Gorboulev, V ;
Akhoundova, A ;
Volk, C ;
Arndt, P ;
Ulzheimer, JC ;
Sonders, MS ;
Baumann, C ;
Waldegger, S ;
Lang, F ;
Koepsell, H .
MOLECULAR PHARMACOLOGY, 1998, 54 (02) :342-352
[7]   Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics [J].
Chen, ML ;
Lee, SC ;
Ng, MJ ;
Schuirmann, DJ ;
Lesko, LJ ;
Williams, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :510-521
[8]   Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter [J].
Cleutjens, KBJM ;
vanEekelen, CCEM ;
vanderKorput, HAGM ;
Brinkmann, AO ;
Trapman, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6379-6388
[9]   TESTOSTERONE AND 5-ALPHA-DIHYDROTESTOSTERONE INTERACT DIFFERENTLY WITH THE ANDROGEN RECEPTOR TO ENHANCE TRANSCRIPTION OF THE MMTV-CAT REPORTER GENE [J].
DESLYPERE, JP ;
YOUNG, M ;
WILSON, JD ;
MCPHAUL, MJ .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 88 (1-3) :15-22
[10]   Chronopharmacology of intravenous and oral modified release verapamil [J].
Dilger, K ;
Eckhardt, K ;
Hofmann, U ;
Kucher, K ;
Mikus, G ;
Eichelbaum, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (04) :413-419